Doxazosin, a quinazoline-derivative, selectively antagonizes postsynaptic alpha1-adrenergic receptors, used in the treatment of high blood pressure and urinary retention associated with benign prostatic hyperplasia.
Molecular Weight:
547.58
Purity:
>98.0%
CAS Number:
[77883-43-3]
Formula:
C23H25N5O5.CH4O3S
Target:
Adrenergic Receptor
* VAT and and shipping costs not included. Errors and price changes excepted